Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL
Shen Kiat Lim, Chen Chen Peng, Shannon Low, Varsheni Vijay, Andrea Budiman, Beng Hooi Phang, Jing Quan Lim, Anand D. Jeyasekharan, Soon Thye Lim, Choon Kiat Ong, Suet‐Mien Tan, Yinghui Li
Topics & Concepts
RELBDoxorubicinCancer researchBiologyCHOPReprogrammingPharmacologyLymphomaImmunologyNFKB1ChemotherapyGeneticsCellGeneTranscription factorUbiquitin and proteasome pathwaysHistone Deacetylase Inhibitors ResearchProtein Degradation and Inhibitors